Opsonix, a Cambridge spinout based on technology from Harvard University, just raised $8 million in a Series A for its device that filters a variety of pathogens from the bloodstream - preventing diseases like sepsis from becoming full-blown.
Fears about the negative effects following a previous attempt at a chlamydia vaccine could soon dissipate with hopeful new research.
Munck Wilson Mandala Partner Greg Howison shared his perspective on some of the legal ramifications around AI, IP, connected devices and the data they generate, in response to emailed questions.
Imagine you break your leg. You pop an oxycodone, and the pain will quickly subside. Physical pain can usually be treated quickly – but the same does not hold true for mental health. For instance, it takes four to 10 weeks for your standard SSRI to kick in and start treating depression. That just isn’t fast enough for patients […]
A new study has found a connection between a pregnant woman’s exposure to air pollution and the chances of her child having autism. Other research has shown a connection in young children, according to IFLScience, but this was the first to collect data across the U.S. looking specifically at the risk for unborn children from […]
A billionaire just gave Harvard University the biggest donation it’s ever received, and all $350 million of it will go to the School of Public Health. It’s one of the university’s lesser-funded schools, according to the Boston Globe, which reported that the school’s endowment as of 2013 totaled $1.1 billion – just a small fraction […]
A simple visual test developed in a lab at Harvard University is taking aim at sickle cell disease, a major public health concern for some developing countries. Unlike in the developed world, regular screening for the genetic blood disorder is not a common practice in Sub-Saharan Africa, where as many as 1 to 2 percent […]
At the Abarca Forward conference earlier this year, George Van Antwerp, managing director at Deloitte, discussed how social determinants of health and a personalized member experience can improve medication adherence and health outcomes.
A competitive game could help physicians and nurses bring patients’ blood pressure levels down faster, according to a study published in Circulation. The idea is to encourage medical professionals to do a better job of intensifying anti-hypertensive medication and avoid clinical inertia. But variations of this game from Qstream are also used to help reinforce […]
If cancer treatment were cheaper and easier to administer, it would be more accessible to early-stage cancer patients across the world. That’s the reasoning behind a disposable, electronic chemotherapy patch designed by a bright group of undergrads at Harvard. The students, under the company name Theratech, just won a $20,000 cash prize from the Create […]
When a company sets out to enter a market inhabited by heavyweights like LabCorp and Quest Diagnostics, it better have something good. Good Start Genetics has applied next-generation DNA sequencing to existing knowledge and testing methods to come up with what it thinks is that something special. The company has developed a series of […]
Biopharmaceutical company Aileron Therapeutics Inc. is ready to advance what it says is a new class of drugs called stapled peptides into clinical trials after boosting its series D round to $42 million. The Cambridge, Massachusetts, company has closed a $12 million second tranche of its Series D round from investors Apple Tree Partners, Excel […]
We will highlight Build My Health's revenue practice management tools, which could help physician practices add up to $250,000 to their practices.